All-cause admissions following a first-ever exacerbation-related hospitalization in COPD
Source : https://openres.ersjournals.com/content/early/2022/08/11/23120541.00217-2022
Background Hospital admissions are important contributors to the overall burden of chronic obstructive pulmonary disease (COPD). Understanding the patterns and causes of hospital admissions will help to identify targets for...
Conclusion: Hospital admissions following a first exacerbation-related hospitalization are common, non-respiratory events constitute the majority of admissions. Besides the respiratory causes, treatment targeting the non-respiratory causes of hospital admission should be considered to effectively decrease the burden of hospitalization in COPD.
The association between respiratory diseases and periodontitis. A systematic review and meta-analysis - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/36606394/
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site. The site is secure....
Conclusions: A positive association between periodontitis and COPD, OSA and COVID-19 complications has been found, while there is a lack of intervention studies.
Noninvasive positive pressure in acute exacerbations of chronic obstructive pulmonary disease - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/36594451/
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site. The site is secure....
Conclusions: The use of NIV in AECOPD is the standard of care as it has demonstrated benefits in several patient-centered outcomes. Current developments and research is related to the implementation and adjustment of NIV.
Prevalence of covid-19 among patients with chronic obstructive pulmonary disease and tuberculosis
Source : https://www.tandfonline.com/doi/full/10.1080/07853890.2022.2160491
Abstract Abstract The exhaustive information about non-communicable diseases associated with COVID-19 and severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) are getting easier to find in the literature. However, there is...
Conclusions: According to the findings, the most significant contributor to an increased risk of morbidity and mortality in TB and COPD patients was the COVID-19.
RIPK1 kinase-dependent inflammation and cell death contribute to the pathogenesis of COPD - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/36549711/
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site. The site is secure....
Conclusions: RIPK1 kinase inhibition is protective in experimental models of COPD and may represent a novel promising therapeutic approach.